Vanderbilt University Medical Center Selects Latent to Support Medication Access
Initiative focuses on improving efficiency in pharmacy workflows.
Nashville, TN and San Francisco, CA— September 22, 2025 — Vanderbilt University Medical Center (VUMC) has selected Latent, an AI-enabled medication access platform, to support specialty and infusion prior authorization workflows. The effort is designed to streamline administrative processes and create efficiencies in pharmacy operations. Latent’s platform uses large language models to analyze the patient chart and surface the clinical information required for prior authorization, reducing review and submission cycles from hours to minutes. The system is designed to improve first-pass approvals and shorten time to therapy. It integrates with Epic and related operational tools to support clinic, pharmacy, and infusion teams. “This initiative reflects our vision for medication access technology—fast, reliable, and deeply integrated in the health system environment,” said Sri Somasundaram, Co-Founder of Latent. “By reducing administrative bottlenecks in specialty and infusion, we can enable staff to focus more on patient care and extend support to adherence and the broader care journey.” About Latent Latent is a health technology company focused on streamlining medication access. Its platform uses clinical AI to support prior authorizations, 340B compliance, and appeals. By optimizing pharmacy workflows and enabling centralization, Latent aims to accelerate time-to-therapy, support scalable pharmacy expansion, and reduce administrative burden on staff. Learn more at www.latenthealth.com.
About Latent Health
Latent Health is the leading AI platform for medication access. The company brings clinical intelligence directly into the patient record, helping care teams move patients from clinical decision to therapy faster and more reliably. Latent is helping more than 2 million patients annually and is trusted by more than 45 of the nation's leading health systems, including Yale New Haven Health, Ochsner Health, MetroHealth, UCI, Vanderbilt Health, Mount Sinai Health System, Henry Ford Health System, UCSF Health, and UCLA Health. Founded by Sriram Somasundaram and Rishabh Jain, Latent has raised $80M in total funding from Transformation Capital, Spark Capital, McKesson Ventures, Conviction, General Catalyst, Y Combinator, and others. To learn more, visit latenthealth.com, and see open roles at latenthealth.com/careers.
For media-related inquiries, please contact press@latent.com.